Form D · Pharmaceuticals
ACUSPHERE INC
Lexington, MA · CIK 0001115143
Offering snapshot reported Feb 22, 2012 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 15, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 22, 2012 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Jul 7, 2011 | Amendment | $7,500,000 | $2,500,000vs Jul 16, 2010 | 1 | SEC filing |
| Jul 16, 2010 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Nov 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173808
Senior Convertible Promissory Note
Source: Form D, filed Feb 22, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Baldino, Jr | Director |
| Garen Bohlin | Director |
| Sandra L. Fenwick | Director |
| Bryant Fong | Director |
| Martyn Greenacre | Director |
| Victor A. Hebert | Director |
| Derek Lemke Von Ammon | Director |
| Sherri C. Oberg | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
99 Hayden Avenue, Suite 385
Lexington, MA, 02421
Lexington, MA, 02421